We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $113B
1-Year Est. Return 38.87%
This Fund
S&P 500
This Quarter Est. Return
+6.68%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$84.9B
AUM Growth
+$3.96B
Cap. Flow
-$732M
Cap. Flow %
-0.86%
Top 10 Hldgs %
17.12%
Holding
814
New
62
Increased
269
Reduced
330
Closed
71

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$415M
2
PHG icon
Philips
PHG
+$332M
3
TXN icon
Texas Instruments
TXN
+$300M
4
GE icon
GE Aerospace
GE
+$283M
5
DVA icon
DaVita
DVA
+$262M

Sector Composition

Rank Sector Weight
1 Financials 28.58%
2 Technology 16.65%
3 Healthcare 11.71%
4 Industrials 11.38%
5 Energy 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XEC
126
DELISTED
CIMAREX ENERGY CO
XEC
$221M 0.26%
1,812,143
+395,877
+28% +$46.2M
BDC icon
127
Belden
BDC
$4.49B
$221M 0.26%
2,861,363
+597,026
+26% +$49.3M
CAH icon
128
Cardinal Health
CAH
$54.5B
$214M 0.25%
3,495,466
+577,099
+20% +$35.7M
AMTD
129
DELISTED
TD Ameritrade Holding Corp
AMTD
$213M 0.25%
4,156,751
+1,221,924
+42% +$61.1M
LEA icon
130
Lear
LEA
$8.2B
$209M 0.25%
1,185,890
+16,426
+1% +$2.88M
MRSH
131
Marsh
MRSH
$92.3B
$204M 0.24%
2,506,998
-294,519
-11% -$24.5M
VR
132
DELISTED
Validus Hold Ltd
VR
$201M 0.24%
4,279,398
+3,893,816
+1,010% +$192M
PCAR icon
133
PACCAR
PCAR
$65.8B
$192M 0.23%
4,044,024
+809,872
+25% +$38.3M
QRVO icon
134
Qorvo
QRVO
$8.25B
$191M 0.23%
2,869,210
+924,017
+48% +$67.3M
GOOG icon
135
Alphabet (Google) Class C
GOOG
$4.19T
$190M 0.22%
3,624,840
-22,860
-0.6% -$1.16M
REG icon
136
Regency Centers
REG
$13.8B
$187M 0.22%
2,702,234
+99,819
+4% +$6.59M
LYG icon
137
Lloyds Banking Group
LYG
$85.7B
$185M 0.22%
49,446,281
-1,580,516
-3% -$5.7M
BSX icon
138
Boston Scientific
BSX
$67.7B
$185M 0.22%
7,475,797
+276,390
+4% +$7.62M
UHS icon
139
Universal Health Services
UHS
$10.1B
$184M 0.22%
1,620,863
+78,225
+5% +$8.36M
UNM icon
140
Unum
UNM
$14.7B
$179M 0.21%
3,256,066
-3,214,896
-50% -$173M
DEI icon
141
Douglas Emmett
DEI
$1.98B
$174M 0.21%
4,241,523
+159,421
+4% +$6.44M
TSE
142
DELISTED
Trinseo
TSE
$169M 0.2%
+2,321,430
New +$165M
CW icon
143
Curtiss-Wright
CW
$22B
$164M 0.19%
1,343,601
-17,956
-1% -$2.12M
JAZZ icon
144
Jazz Pharmaceuticals
JAZZ
$16B
$161M 0.19%
+1,199,188
New +$166M
GL icon
145
Globe Life
GL
$13.4B
$160M 0.19%
1,762,346
-122,146
-6% -$10.5M
ETFC
146
DELISTED
E*Trade Financial Corporation
ETFC
$160M 0.19%
3,218,402
+186,549
+6% +$8.56M
MSCC
147
DELISTED
Microsemi Corp
MSCC
$159M 0.19%
3,074,329
+73,916
+2% +$3.89M
NFX
148
DELISTED
Newfield Exploration
NFX
$157M 0.19%
4,992,265
-634,772
-11% -$19.3M
CTSH icon
149
Cognizant
CTSH
$29B
$157M 0.18%
2,208,803
+23,128
+1% +$1.69M
DTE icon
150
DTE Energy
DTE
$28.2B
$156M 0.18%
+1,678,625
New +$160M

Similar funds

Boston Partners's Q4 2017 Portfolio in Review

As of Q4 2017, Boston Partners held 814 positions worth $84.9B, up 4.9% from $80.9B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Boston Partners's Q4 2017 filing shows 62 new, 269 increased, 330 reduced and 71 closed positions. Its largest new stake was Everest Group: 1,740,653 shares worth $385M. The largest sale was Abbott, an estimated $415M.

By sector, the portfolio is most concentrated in Financials at 29% of assets, up from 28% a quarter earlier, followed by Technology and Healthcare.

  • Boston Partners's largest Q4 2017 buy was Everest Group: 1,740,653 shares worth $385M.
  • Boston Partners added most to Royal Dutch Shell PLC ADS Class A in Q4 2017, an estimated $398M increase.
  • Boston Partners's biggest Q4 2017 reduction was Abbott, cutting an estimated $415M.
  • Boston Partners fully exited Philips in Q4 2017, selling an estimated $332M.
  • Boston Partners's ten largest holdings make up 17% of its $84.9B portfolio in Q4 2017.
  • Boston Partners opened 62 new positions and closed 71 in Q4 2017.
  • Boston Partners's portfolio value rose 4.9% quarter-over-quarter to $84.9B.

Based on Boston Partners's 13F filing for Q4 2017, filed 1 Feb 2018.